SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-065932
Filing Date
2017-03-01
Accepted
2017-03-01 16:56:58
Documents
10
Period of Report
2017-03-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d355886d8k.htm 8-K 27341
2 EX-99.1 d355886dex991.htm EX-99.1 7452
3 GRAPHIC g355886ex99_1s1g1.jpg GRAPHIC 231784
4 GRAPHIC g355886ex99_1s2g1.jpg GRAPHIC 257488
5 GRAPHIC g355886ex99_1s3g1.jpg GRAPHIC 218009
6 GRAPHIC g355886ex99_1s4g1.jpg GRAPHIC 246770
7 GRAPHIC g355886ex99_1s5g1.jpg GRAPHIC 220453
8 GRAPHIC g355886ex99_1s6g1.jpg GRAPHIC 236544
9 GRAPHIC g355886ex99_1s7g1.jpg GRAPHIC 241745
10 GRAPHIC g355886ex99_1s8g1.jpg GRAPHIC 252418
  Complete submission text file 0001193125-17-065932.txt   2660925
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 17655083
SIC: 2834 Pharmaceutical Preparations